A Stress Inducible Protein Sestrin2 in Heart Failure

心力衰竭中的应激诱导蛋白 Sestrin2

基本信息

  • 批准号:
    10616476
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-01 至 2026-03-31
  • 项目状态:
    未结题

项目摘要

Heart failure is an increasingly prevalent problem and particularly so amongst an aging Veterans population. From a clinical standpoint, the prevalence of comorbid conditions such as obesity, diabetes, COPD (chronic obstructive pulmonary disease), aging and hypertension in these patients has led to the inflammatory hypothesis where heart failure is also associated with coronary microvascular dysfunction. Nevertheless, the causal importance of maladaptive substrate metabolism and impaired coronary flow regulation in the development of the heart failure remain unclear. The work described in this proposal combines experiments at the basic and translational research level to address the critical need of our veterans for novel and effective heart failure therapies. The long-term goal of our research is to understand the molecular mechanisms that underlie the role of Sestrin2 (Sesn2), a stress inducible protein, in mediating progression from compensated left ventricular hypertrophy to decompensated hypertrophy and maladaptive ventricular remodeling in heart failure. We have demonstrated that Sesn2 is a mediator of physiologic and pathologic cardiac hypertrophy and are now seeking to define the underlying molecular mechanisms. Sesn2 knockout (Sesn2 KO) mice display normal cardiac function at rest compared to wild type (WT) littermates but are vulnerable with pathologic hypertrophy in response to pressure overload. Furthermore, recently published data from our lab show that Sesn2 serves as an age- related protein that modulates AMPK, a cardiac energy sensor, to maintain metabolic homeostasis under stress conditions. Aging related heart failure could be due to impaired Sesn2-AMPK signaling cascade occurring in synergy with the adverse effects of hypertension. Thus, our central hypothesis is that Sesn2 serves as a scaffold protein that plays a key role in hypertension induced heart failure in aging. Aim 1: To determine the upstream signaling pathways that control cardiac Sesn2 expression, and the mechanisms by which Sesn2-mediated AMPK signaling inhibits development of hypertension-induced heart failure in aging. Aim 2: To determine the role of Sesn2-mTORC1 complex in the cardiac response to hypertension and aging. Our long-term objective is to improve the care of Veterans with heart failure by developing a better understanding of the mechanisms leading to heart failure and identifying novel targeted treatments that can prevent or reverse hypertensive heart failure.
心力衰竭是一个日益普遍的问题,尤其是在年迈的退伍军人中 人口。从临床的角度来看,肥胖、糖尿病、 COPD(慢性阻塞性肺疾病)、老龄化和高血压导致这些患者 炎症假说,心力衰竭也与冠脉微血管功能障碍有关。 然而,不适应底物代谢和冠状动脉血流受损的原因重要性 心力衰竭的发展过程中的调控尚不清楚。这份建议书中描述的工作 结合基础研究和翻译研究层面的实验,以满足我们的关键需求 新的有效的心力衰竭治疗的退伍军人。我们研究的长期目标是 了解压力诱导蛋白Sestrin2(Sesn2)作用的分子机制 蛋白质在左心室代偿性肥厚向失代偿期进展中的调节作用 心力衰竭患者的肥厚和适应性不良的心室重构。我们已经证明了Sesn2是 一种生理性和病理性心肌肥厚的介体,现在正在寻求定义 潜在的分子机制。Sesn2基因敲除(Sesn2 KO)小鼠在 与野生型(WT)产仔相比,REST容易出现病理性肥大 压力过载。此外,我们实验室最近公布的数据显示,Sesn2作为一个年龄- 调节AMPK的相关蛋白质,AMPK是心脏能量感受器,在 压力条件。衰老相关的心力衰竭可能是由于Sesn2-AMPK信号通路受损所致 与高血压的不良影响协同发生的。因此,我们的中心假设是Sesn2 作为一种支架蛋白,在高血压引起的衰老心力衰竭中发挥关键作用。目标1:实现 确定控制心脏Sesn2表达的上游信号通路及其机制 Sesn2介导的AMPK信号通路抑制高血压大鼠心力衰竭的研究 衰老。目的2:确定Sesn2-mTORC1复合体在高血压心脏反应中的作用 和衰老。我们的长期目标是通过发展一种 更好地了解导致心力衰竭的机制并确定新的靶向治疗方法 可以预防或逆转高血压性心力衰竭。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ji Li其他文献

Ji Li的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ji Li', 18)}}的其他基金

A Stress Inducible Protein Sestrin2 in Heart Failure
心力衰竭中的应激诱导蛋白 Sestrin2
  • 批准号:
    10363811
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
A Stress Inducible Protein Sestrin2 in Heart Failure
心力衰竭中的应激诱导蛋白 Sestrin2
  • 批准号:
    11002402
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Activated Protein C in Acute Injury
急性损伤中的活化蛋白 C
  • 批准号:
    10475352
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
MIF and Cardiovascular Inflammation
MIF 与心血管炎症
  • 批准号:
    10269328
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
MIF and Cardiovascular Inflammation
MIF 与心血管炎症
  • 批准号:
    10827626
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
MIF and Cardiovascular Inflammation
MIF 与心血管炎症
  • 批准号:
    10450128
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Activated Protein C and Cardiac Inflammatory Response
活化蛋白 C 与心脏炎症反应
  • 批准号:
    10393231
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Activated Protein C and Cardiac Inflammatory Response
活化蛋白 C 与心脏炎症反应
  • 批准号:
    10004784
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
AMPK-SIRT1 Signaling in the Adaptive Metabolic Response
适应性代谢反应中的 AMPK-SIRT1 信号传导
  • 批准号:
    9114282
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
AMPK-SIRT1 Signaling in the Adaptive Metabolic Response
适应性代谢反应中的 AMPK-SIRT1 信号传导
  • 批准号:
    9243202
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了